HDFC Pharma and Healthcare Fund - Regular (G)

HDFC Pharma and Healthcare Fund - Regular (G) - Portfolio Analysis

Portfolio Overview

As of November 30, 2025

Asset Allocation

Equity: 98.38%Others: 1.62%

Market Cap

Large Cap: 26.28%Mid Cap: 30.37%Small Cap: 32.94%Equity: 8.78%

Number of stocks

32

Top 10 Holdings

120.71% of portfolio

Market Cap of Equity

Large Cap
26.2784%
Mid Cap
30.3746%
Small Cap
32.9441%
Equity
8.7837%

Companies Allocation of Equity

Sun Pharmaceuticals Industries Ltd22.67%
Divi's Laboratories Ltd16.69%
Lupin Ltd12.80%
Glenmark Pharmaceuticals Ltd12.17%
Max Healthcare Institute Ltd Ordinary Shares12.14%
Alkem Laboratories Ltd11.78%
Ipca Laboratories Ltd9.21%
Laurus Labs Ltd8.04%
Anthem Biosciences Ltd7.78%
Torrent Pharmaceuticals Ltd7.42%

Sector Allocation of Equity

Healthcare95.41%
Basic Materials2.97%

SIP Amount

Monthly SIP Date

HDFC Pharma and Healthcare Fund - Regular (G)

Suitabilty Test For Finding this Fund is Suitable or Not for User.Suitabilty Test For Finding this Fund is Suitable or Not for User.
Is This Mutual Fund Right for You?

+10k investors used our Suitability Test to get better returns

Frequently Asked Questions

Everything You Need To Know To Get Started With Confidence

In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.